Quanjie Li Selected Research

Infections

4/2024	CX-6258 hydrochloride hydrate: A potential non-nucleoside inhibitor targeting the RNA-dependent RNA polymerase of norovirus.
2/2023	Transcriptome analysis of the response of four immune related organs of tilapia (Oreochromis niloticus) to the addition of resveratrol in feed.
12/2022	Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro.
1/2022	Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis.
1/2022	MxB Disrupts Hepatitis C Virus NS5A-CypA Complex: Insights From a Combined Theoretical and Experimental Approach.
8/2021	The CREB Regulated Transcription Coactivator 2 Suppresses HIV-1 Transcription by Preventing RNA Pol II from Binding to HIV-1 LTR.
1/2020	Identification of a Broad-Spectrum Viral Inhibitor Targeting a Novel Allosteric Site in the RNA-Dependent RNA Polymerases of Dengue Virus and Norovirus.
1/2020	Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
11/2019	Influenza Virus Exploits an Interferon-Independent lncRNA to Preserve Viral RNA Synthesis through Stabilizing Viral RNA Polymerase PB1.
1/2018	Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quanjie Li Research Topics

Disease

10	Infections 04/2024 - 01/2018
4	COVID-19 12/2022 - 01/2021
3	Inborn Genetic Diseases (Disease, Hereditary) 10/2023 - 01/2022
2	Inflammation (Inflammations) 04/2024 - 08/2023
2	Zika Virus Infection 01/2024 - 11/2022
1	Bone Resorption 04/2024
1	Cardiotoxicity 12/2023
1	Fatigue 08/2023
1	Leukopenia 12/2022
1	Neoplasms (Cancer) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Pain (Aches) 10/2019

Drug/Important Bio-Agent (IBA)

3	Viral RNAIBA 12/2022 - 11/2019
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2019
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	PrometryneIBA 12/2023 - 08/2023
2	ElementsIBA 10/2023 - 01/2022
1	Phosphotransferases (Kinase)IBA 04/2024
1	CX-6258IBA 04/2024
1	Actins (F Actin)IBA 04/2024
1	LigandsIBA 04/2024
1	PropionatesIBA 04/2024
1	EnzymesIBA 04/2024
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2024
1	VaccinesIBA 01/2024
1	Peroxisome ProliferatorsIBA 02/2023
1	Cell Adhesion MoleculesIBA 02/2023
1	Mitogen-Activated Protein KinasesIBA 02/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2023
1	Peptide Hydrolases (Proteases)FDA Link 12/2022
1	berbamine (penduline)IBA 12/2022
1	Histamine Antagonists (Antihistamines)IBA 11/2022
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 11/2022
1	diazolineIBA 11/2022
1	LipidsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Retroelements (Retrotransposon)IBA 01/2022
1	Cyclophilin AIBA 01/2022
1	Interferon Type IIBA 01/2022
1	remdesivirIBA 12/2021
1	corilaginIBA 06/2021
1	NucleosidesIBA 06/2021
1	Amino Acids FDA Link 01/2020
1	Viral DNAIBA 01/2020
1	entrectinibIBA 01/2020
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 11/2019
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 10/2019
1	ArrestinIBA 10/2019
1	Long Noncoding RNAIBA 01/2018
1	InterferonsIBA 01/2018

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2018